Iovate

Iovate is a dietary supplement manufacturer that serves as a prominent case study for the severe financial and legal risks associated with the clinical-substantiation-gap in the United States wellness market.

The company faced a $5.5 million settlement with the ftc over false advertising charges related to unsubstantiated weight-loss claims. As part of the settlement, Iovate was barred from making future health claims without extensive clinical proof and prior fda approval for any disease claims. This enforcement action underscores the FTC’s strict requirement for “competent and reliable scientific evidence” when marketing functional foods and dietary supplements.